| payload |
{"created_at":"2026-04-08T13:58:12.891 {"created_at":"2026-04-08T13:58:12.891113+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/adaptive-biotech-insider-sells-554k-revenue-jumps-55-heres-what-investors-should-focus","value":{"fp":"016787c964d0e851","kind":"unusual_volume","published_at":"2026-04-08T13:33:15+00:00","source":"Nasdaq Markets","summary":"Key PointsThe President and COO of Adaptive Biotechnologies Corporation reported the sale of 38,120 shares for about $554,000, based on a weighted average transaction price of $14.53 per share across April 1\u20132, 2026.","tickers":[],"title":"Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On","url":"https://www.nasdaq.com/articles/adaptive-biotech-insider-sells-554k-revenue-jumps-55-heres-what-investors-should-focus"}}... |